Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Targeting BRAF for patients with melanoma Arkenau HT; Kefford R; Long GVBr J Cancer 2011[Feb]; 104 (3): 392-8The prognosis of patients with metastatic melanoma is poor and not influenced by systemic therapy with cytotoxic drugs. New targeted agents directed against the RAS-RAF-MEK-ERK pathway show promising activity in early clinical development and particular interest is focused on selective inhibitors of mutant BRAF, which is present in one half of the cases of metastatic melanoma. The majority of patients on early trials of these drugs develop secondary resistance and subsequent disease progression and it is, therefore, critical to understand the underlying escape mechanisms leading to resistance.|*Drug Resistance, Neoplasm[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Humans[MESH]|Melanoma/genetics/secondary/*therapy[MESH]|Mutation[MESH]|Prognosis[MESH]|Protein Kinase Inhibitors/therapeutic use[MESH]|Proto-Oncogene Proteins B-raf/*antagonists & inhibitors/*genetics[MESH]|Skin Neoplasms/genetics/pathology/*therapy[MESH] |